首页> 外文期刊>Modern Pathology >Pulmonary Pathology of Erdheim-Chester Disease
【24h】

Pulmonary Pathology of Erdheim-Chester Disease

机译:Erdheim-Chester病的肺部病理

获取原文
           

摘要

Erdheim-Chester disease (ECD) is a rare non-Langerhans' cell histiocytosis that may present with pulmonary symptoms. The condition seems to be nonfamilial and typically affects middle-aged adults. Radiographic and pathologic changes in the long bones are diagnostic, but patients often present with extraskeletal manifestations. Advanced pulmonary lesions are associated with extensive fibrosis that may lead to cardiorespiratory failure. The clinical, radiologic, and pathologic features of six patients with ECD with lung involvement are presented. The patients were three men and three women (mean age, 57). Five presented with progressive dyspnea, and one presented with diabetes insipidus. Open-lung biopsies showed histiocytic infiltrates in a lymphangitic pattern with associated fibrosis and lymphoplasmacytic inflammatory infiltrates. The histiocytes did not stain with periodic acid-Schiff. Immunoperoxidase studies performed on specimens from five of six patients showed that the histiocytes were positive for CD68 and Factor XIIIa and negative for CD1a. Specimens from two patients exhibited immunoreactivity for S-100 protein. Electron microscopy studies performed on specimens from two patients showed phagocytic lysosomes but no Birbeck granules. Clinical follow-up of up to 16 years was available. At the end of that time, five patients were dead of complications related to their disease; one patient remains alive 4 years after diagnosis but with severe respiratory compromise. ECD is a rare non-Langerhans' cell histiocytosis that may present as interstitial lung disease and resemble other pulmonary conditions, particularly usual interstitial pneumonitis and pulmonary Langerhans' cell histiocytosis. Recognition of this entity will allow better assessment of its true incidence, therapeutic options, and prognosis.
机译:Erdheim-Chester病(ECD)是一种罕见的非朗格汉斯细胞组织细胞增生症,可能伴有肺部症状。该病似乎是非家族性的,通常会影响中年成年人。长骨的放射学和病理学改变是诊断性的,但患者通常表现为骨骼外表现。晚期肺部病变与广泛的纤维化有关,可能导致心肺功能衰竭。介绍了6例肺部受累的ECD患者的临床,影像学和病理学特征。患者为三男三女(平均年龄57岁)。五例表现为进行性呼吸困难,一例表现为尿崩症。肺活检显示淋巴管炎的组织细胞浸润伴有纤维化和淋巴胞浆炎性浸润。组织细胞不被高碘酸-希夫染色。对六名患者中五名患者的标本进行的免疫过氧化物酶研究表明,组织细胞CD68和XIIIa因子阳性,而CD1a阴性。两名患者的标本对S-100蛋白具有免疫反应性。对两名患者的标本进行的电子显微镜研究显示,吞噬性溶酶体但没有Birbeck颗粒。可获得长达16年的临床随访。到那时候结束时,有五名患者死于与疾病有关的并发症;一名患者在诊断后4年仍存活,但存在严重的呼吸困难。 ECD是一种罕见的非朗格汉斯细胞组织细胞增生症,可表现为间质性肺疾病,并与其他肺部疾病相似,尤其是通常的间质性肺炎和肺朗格汉斯细胞组织细胞增生症。识别该实体将可以更好地评估其真实发生率,治疗选择和预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号